REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | Advertising Agencies | Packaging and Labeling Services
Full name: Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce Profile Updated: September 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce is based in Poland. The head office is in Warszawa. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was established on April 12, 2021. From the latest financial highlights, Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce reported a net sales revenue drop of 56.13% in 2024. Its total assets grew by 38.89% over the same period.

Headquarters
Ul. Adama Branickiego 15 009
Warszawa; Mazowieckie; Postal Code: 02-972

Contact Details: Purchase the Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce report to view the information.

Basic Information
Financial Auditors:
Purchase the Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce report to view the information.
Incorporation Date:
April 12, 2021
Key Executives
Purchase this report to view the information.
Power of Attorney
Company Performance
Financial values in the chart are available after Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-56.13%
Total operating revenue
-56.17%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
38.89%
Total Equity
44.16%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.01%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?